Literature DB >> 2368148

Noninvasive monitoring of human cardiac allograft rejection.

J A Reader1, M M Burke, P Counihan, J A Kirby, S Adams, M J Davies, J R Pepper.   

Abstract

The frequency of donor-reactive cytolytic T lymphocytes was measured in the peripheral blood mononuclear cell population of a group of 12 cardiac allograft recipients immediately before and at various time points after transplantation. At each of the time points after transplantation the donor heart was biopsied and the rejection status of the graft was determined by applying standard histological criteria. The results of this study showed that the preoperative frequency of donor-reactive cytolytic T lymphocytes in the blood was not predictive of a future tendency toward graft rejection. However, when all the data were examined it was apparent that the frequency of donor-reactive cytolytic T lymphocytes was significantly higher (P less than 0.05) in blood samples from patients whose simultaneous biopsy showed histological evidence of acute cardiac allograft rejection than in blood samples from transplant patients showing no evidence of rejection.

Entities:  

Mesh:

Year:  1990        PMID: 2368148     DOI: 10.1097/00007890-199007000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation.

Authors:  L M Vaessen; C R Daane; A P Maat; A H Balk; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood.

Authors:  L M Vaessen; C C Baan; A J Ouwehand; N H Jutte; A H Balk; B Mochtar; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Soluble CD8 and CD25 in serum of patients after heart transplantation.

Authors:  P L Wijngaard; A Van der Meulen; F H Gmelig Meyling; N De Jonge; H J Schuurman
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

4.  Development of immunological assays to monitor pulmonary allograft rejection.

Authors:  A C Cunningham; J A Kirby; I W Colquhoun; P A Flecknell; T Ashcroft; J H Dark
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

5.  Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes.

Authors:  A C Cunningham; T J Butler; J A Kirby
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

6.  Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection.

Authors:  K Hisatomi; T Isomura; E Tayama; K Tamehiro; M Ohashi; T Sato; K Kosuga; K Ohishi; Y Imai; K Itoh
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Is cytoimmunological monitoring a safe follow-up method for heart transplantation patients?

Authors:  Faruk Cingoz; Celalettin Gunay; Bilgehan Savas Oz; Mehmet Arslan
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.